Small human study

Semax

Attention, focus, and brain research, mostly in Russian studies. Approved as a nasal medicine in Russia. Not FDA-approved.

15-second reel. It plays silently on a loop.

What it is

Semax is a Russian-origin neuropeptide, a synthetic analogue of a fragment of ACTH, discussed for attention, focus, and thinking. It is often mentioned alongside Selank, in a brain-research lane — not as a proven smart drug. The reel says it in one line — a peptide studied for focus and thinking. Mostly Russian studies. A nasal drug there. Not FDA-approved. In Russia it is an approved nasal medicine. It is not approved by the U.S. Food and Drug Administration. Show the Study does not prescribe it and does not supply it.

Studied for

  • Attention, focus, and cognition research — the research question, not a proven everyday effect.
  • Acute ischemic stroke, in published clinical papers from Russian research groups.
  • Brain-network activity in small human imaging studies.
  • Laboratory work on nerve-growth signals and neuroprotection in animals.

The evidence

Small human study. There are published human stroke and brain-imaging studies, mostly from Russian research groups. In Russia it is approved as a nasal medicine. The stroke papers are clinical reports, not large modern international randomized trials, and independent Western confirmation is limited. Changes on a brain scan are not the same as improved memory, focus, or recovery. Semax is not FDA-approved. This page does not treat clinic stories as a substitute for that missing international trial record.

What this page will not do

  • We do not describe it as a proven smart drug, or as a treatment for stroke, Parkinson’s disease, or “brain fog.”
  • Approval in Russia is not the same as FDA approval, and we do not give a dose, a route, or a place to buy it.
  • Animal findings about nerve-growth signals or toxin models are not human outcome evidence.

Still open

  • Whether large, independently run international trials with measured thinking or recovery outcomes get published.
  • How to read older or Russian-language clinical papers against modern trial standards.
  • Whether imaging changes in small studies predict a benefit a person would notice.

Educational content only. This page does not diagnose, treat, cure, or prevent anything, and it is not a dose. Talk with a licensed physician before starting, stopping, or changing any medication. Library reviewed November 2026.